drugset / Trial / NCT01196455
Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer
Phase 2
Unknown
39 enrolled
Croatian Cooperative Group for Clinical Research in Oncology
Roche Pharma AG · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, non-comparative efficacy and safety study of Capecitabine and Mitomycin C as first-line treatment in patients with previously untreated metastatic breast cancer.
Timeline
- Start
- 2006-03
- Primary completion
- 2011-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Mitomycin C | Other / unclassified | 8 mg/m2 | Intravenous |